Internal Medicine, Endocrinology, Diabetes, & Metabolism · Reno, NV
NPI
1336156546
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
540 W Plumb Ln, Suite 2a
Reno, NV, 89509
Phone (775) 348-1811
Groups this clinician bills Medicare through
Medicare paid, 2024
$123K
1,443 services
Medicare patients, 2024
334
Average age 74
Drug cost, 2024
$3.5M
5,704 prescriptions
Company payments, 2025
$1,627
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert S Fredericks was code 99214 (office e&m - established), 1,165 times for 303 patients. In total Robert S Fredericks billed 1,443 services in 4 codes, and Medicare paid $123K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,165 | 303 | $82.83 | $97K |
| 99443 Telephone Services | Office | 211 | 100 | $83.76 | $18K |
| 99205 Office E&M - New | Office | 65 | 65 | $141.41 | $9,192 |
By year: 2022 $118K for 1,276 services; 2023 $123K for 1,337 services; 2024 $123K for 1,443 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert S Fredericks prescribed most often to Medicare patients was Liothyronine Sodium, with 432 prescriptions and refills. In total Robert S Fredericks wrote 5,704 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Liothyronine Sodium Generic | 432 | 965 | 116 | $34K |
| Levothyroxine Sodium Generic | 344 | 1,006 | 103 | $5,708 |
| Synthroid Levothyroxine Sodium | 219 | 565 | 52 | $25K |
| Calcitonin-Salmon Calcitonin,salmon,synthetic | 217 | 429 | 70 | $22K |
| Jardiance Empagliflozin | 180 | 457 | 50 | $263K |
| Pioglitazone Hcl Generic | 155 | 391 | 50 | $1,625 |
| Calcitriol Generic | 131 | 372 | 36 | $4,085 |
| Paricalcitol Generic | 113 | 302 | 39 | $19K |
| Mounjaro Tirzepatide | 111 | 176 | 22 | $185K |
| Clonidine Hcl Generic | 103 | 227 | 28 | $743 |
| Memantine Hcl Generic | 99 | 194 | 26 | $1,571 |
| Aliskiren Aliskiren Hemifumarate | 99 | 181 | 23 | $22K |
| Metformin Hcl Generic | 95 | 219 | 25 | $745 |
| Indapamide Generic | 90 | 258 | 34 | $1,361 |
| Genotropin Somatropin | 90 | 95 | 12 | $199K |
Brand drugs: 1,645 claims; generic drugs: 3,961 claims; opioid claims: 113.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert S Fredericks $1,627 ($1,627 in general payments such as food, travel and fees) from 16 companies. The largest payer was Ascendis Pharma Endocrinology Inc with $366.
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc ASND | 7 | $366 |
| Amgen Inc. AMGN | 6 | $221 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $174 |
| Soleno Therapeutics, Inc. SLNO | 2 | $163 |
| Sanofi-Aventis U.S. LLC SNY | 4 | $141 |
| Madrigal Pharmaceuticals MDGL | 2 | $130 |
| Kyowa Kirin, Inc. 4151.T | 3 | $99.44 |
| Beta Bionics, Inc. BBNX | 2 | $73.37 |
| Xeris Pharmaceuticals, Inc. | 1 | $49.66 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $49.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.